Learn
Delve into dermatology diseases with new approaches from conventional to complementary care.
Topics
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Training Programs
Expert led instruction for every level of patient care.
Hover over a program to view enrolled content.
Conferences
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
Join Us
The largest integrative dermatology community.
Itch is the hallmark symptom of atopic dermatitis and the major source of patient suffering. In caring for these patients, it is important to understand the underlying mechanism and the manner in which treatments target these mechanisms to reduce pruritus. This lecture will formulate an approach for the treatment of different types of AD itch and describe upcoming drugs in clinical targeting of itch and AD.
Faculty
Dr. Gil Yosipovitch is a Professor of Dermatology at the Miller School of Medicine at University of Miami, and Director of the Miami Itch Center. The Itch Center focuses on diagnosing and treating chronic itch of different types, conducting research on neuroanatomy and neurophysiology of itch in humans and animal models and developing anti pruritic drugs that target the neural system.
Related Courses
Atopic Dermatitis
Evidence for the Use of Topical Therapies in the Treatment of Atopic Dermatitis
Atopic Dermatitis
Assessing Pediatric Populations for Severe Atopic Dermatitis and When to Treat with Systemic Medications
COVID-19
Review of COVID Vaccine Mechanisms of Action and How Immunomodulatory Medications May Modify the Immune Response to COVID Vaccination
COVID-19
Modification of Systemic MTSAD Treatment Protocols in the COVID Pandemic Environment and When Considering COVID Vaccination
